Lakewood, CO, Oct. 06, 2022 (GLOBE NEWSWIRE) — KRTL International Corp., a completely owned subsidiary of KRTL Holding Group, Inc. (OTC: KRTL), proudly proclaims it has shaped a world strategic alliance with Cannabis Global, Inc. (OTC: CBGL), specializing in one of many quickest rising areas of the hemp and hashish marketplaces: infusion applied sciences together with, water soluble formulations for use in a number of economic merchandise. The new relationship between the businesses may also embody different areas of analysis and growth particular to hemp and hashish shopper merchandise.
Cannabis Global is creating state-of-the-art proprietary supply strategies and infusion applied sciences to permit the Company and its manufacturing companions to infuse hemp and hashish merchandise utilizing all-natural water-soluble emulsions. In addition, Cannabis Global is actively creating all pure nanoparticle and nanofibers hemp and hashish applied sciences utilizing pharmaceutical-grade electrospray applied sciences, for which it has filed for U.S. and worldwide patent safety.
Edward Manolos, CEO of Cannabis Global, commented, “By working with KRTL we hope to expand upon our ground-breaking hemp and cannabis infusion R&D program. With KRTL potentially providing an important distribution channel for products to be based on our technologies. We view this strategic alliance highly beneficial to both companies.”
The events intend to foster a relationship that shares further analysis and growth, co-promotion, company highlights for shared priorities, and different aligned initiatives that profit KRTL and CBGL and allows a mutual aggressive benefit. The Agreement’s intention aligns business methods, objectives, collaborations, allocation of prices, advertising and marketing, bills, revenue sharing methods, and earnings for business performed inside the regulation.
“We are especially interested in Cannabis Global’s infusion technologies relative to our work as foreign advisors to the Special Free Zone in Gyeongbuk Province, Republic of Korea and with our network in various other Asian countries,” mentioned Kai Kim, CEO of KRTL International Corp., a completely owned subsidiary of KRTL Holding Group Inc. (OTC: KRTL). “We believe through this new alliance; we have an opportunity to design and distribute a wide range of products through a network of CGMPs manufacturers for international distribution. Additionally, we will focus on innovative infusions for products that can be potentially first to market. We intend on discussing our plans at MJ BIZ CON which we will be participating in November 2022,” added Kai Kim.
About KRTL Holding Group, Inc.
KRTL is a holding firm curious about diversifying threat and accessing new markets. The Company operates its wholly owned subsidiaries, KRTL Biotech, Inc. and KRTL International Corp., with precision and excellence and continues to create and strengthen the KRTL repute. This permits KRTL Holding Group, Inc. to capitalize on any vary of funding alternatives. Our group values collaboration and emphasizes a clear work surroundings. Additional info on KRTL is accessible on-line at www.krtlholding.com and www.krtl-icc.com and www.krtlbiotech.com.
About CANNABIS GLOBAL, INC.
CANNABIS GLOBAL, Inc through its majority-owned licensed and regulated entities, Natural Plant Extract of California, and Northern Lights Distribution, Cannabis Global is a publicly traded firm centered on delivering long-term shareholder progress and outcomes which might be centered on a number of rising verticals inside the international hashish & CBD trade. This was achieved by partnerships, acquisitions, and mental property. Additional info on CBGL is accessible on-line at www.cannabisglobalinc.com
Forward-Looking Statements
The info contained herein contains forward-looking statements. These statements relate to future occasions or to our future monetary efficiency, and contain identified and unknown dangers, uncertainties and different elements which will trigger our precise outcomes, efficiency, or achievements to be materially totally different from any future outcomes, efficiency or achievements expressed or implied by these forward-looking statements. You mustn’t place undue reliance on forward-looking. We assume no obligation to publicly replace or revise these forward-looking statements for any cause, or to replace the explanations precise outcomes might differ materially from these anticipated in these forward-looking statements, even when new info turns into accessible sooner or later.
